SIA "Ingen Pharma"
Copy
Copy
CopyRegistry data
Legal status
Company ID
CopyVAT code
CopyIncorporation date
Paid share capital
Registered share capital
Contacts
Company registration address
Copy
Website
-Latest events
from (18/11/2021)
2024-11-11
Change in beneficial owners2024-11-11
Change in members2024-11-11
Change in officers2023-08-04
Unidentified type of changeSuspensions
No suspension
Register and unlock the potential of dataReliability
Register and check the change of employees’ number over the years
Number of employees
3Debts
0.00 €
0 €* during past year
Register and check if company had lawsuits over the years
Lawsuits as defendant
0
Credit limit
***** €
Turnover
5-10 M €
+7.36 %Business linkages
9Linkages with other companies
Financial ratios
Net Profit (€)
561,692
EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization and is a metric used to evaluate a company’s operating performance. It can be seen as a proxy for cash flow from the entire company’s operations.EBITDA margin (%)
Enjoy unlimited use
with Freemium unlimitedEBIT margin shows the profitability of a company over a certain period of time.EBIT margin (%)
Enjoy unlimited use
with Freemium unlimitedNet Profit (€)
561,692EBITDA margin (%)
Enjoy unlimited use
with Freemium unlimitedEBIT margin (%)
Enjoy unlimited use
with Freemium unlimitedFinancial statement report
Premium users: 1.00 credit
| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€)Sales per employee is a popular efficiency indicator that is often used to measure a company's performance. The average annual number of employees is usually used to calculate the indicator. |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€)This ratio is on of company's growth indicators. It shows how much profit per employee is earned by the company. |
| Total profitability (%)It is an indicator of company's performance efficiency, calculated as ratio of gross profit to sales revenue. |
| Net profitability (%)This ratio is commonly referred to as a company’s “bottom line” and is a true indicator of a company’s profitability. It shows how much a net profit of € 1 (or other monetary unit) is generated by sales. |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| Current Assets (€) |
| Working capital requirement (%)The working capital requirement indicator shows how much funds a company needs to develop and maintain a business. |
| Debt-to-equity ratioThe debt-to-equity ratio is used to evaluate a company's financial leverage and is calculated by dividing a company’s total liabilities by its shareholder equity.
This ratio is a measure of the degree to which a company is financing its operations through debt versus wholly owned funds. More specifically, it reflects the ability of shareholder equity to cover all outstanding debts in the event of a business downturn. |
| EBITDA margin (%)EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization and is a metric used to evaluate a company’s operating performance. It can be seen as a proxy for cash flow from the entire company’s operations. |
| EBITDA (€)EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. Lenders use EBITDA to calculate a company’s ability to repay a loan and pay interest. |
| EBIT margin (%)EBIT margin shows the profitability of a company over a certain period of time. |
| EBIT (€)EBIT (earnings before interest and taxes) is a company's net income before income tax expense and interest expenses are deducted. EBIT is used to analyze the performance of a company's core operations without the costs of the capital structure and tax expenses impacting profit. |
| 2023 |
|---|
| 5,182,022 |
| 1,727,341 |
| 930,160 |
| 927,073 |
| 309,024 |
| 66.73 |
| 17.89 |
| 3,784,592 |
| 397,048 |
| 125,153 |
| 4,056,487 |
| 2024 |
|---|
| 4,748,745 |
| 1,582,915 |
| 167,582 |
| 165,023 |
| 55,008 |
| 65.93 |
| 3.48 |
| 3,949,615 |
| 1,210,916 |
| 3,215,468 |
| 1,945,063 |
| 2025 |
|---|
| 5,098,411 |
| 1,699,470 |
| 561,692 |
| 561,692 |
| 187,231 |
| 68.55 |
| 11.02 |
| 4,007,301 |
| 1,676,143 |
| 3,237,786 |
| 2,445,658 |
Enjoy unlimited use
with Freemium unlimited| 2025 |
|---|
| 5,098,411 |
| 1,699,470 |
| 561,692 |
| 561,692 |
| 187,231 |
| 68.55 |
| 11.02 |
| 4,007,301 |
| 1,676,143 |
| 3,237,786 |
| 2,445,658 |
Enjoy unlimited use
with Freemium unlimitedTurnover (€)
2025
Turnover (€)
5,098,411 €
7 % *
Sales per employee (€)
1,699,470 €7 % *
Profit before tax (€)
561,692 €235 % *
Net Profit (€)
561,692 €240 % *
Profit per employee (€)
187,231 €240 % *
Total profitability (%)
68.55 %3.97 % *
Net profitability (%)
11.02 %216.67 % *
Equity (€)
4,007,301 €1 % *
Amounts Payable And Liabilities (€)
1,676,143 €
38 % *
Non-current Assets (€)
3,237,786 €1 % *
Current Assets (€)
2,445,658 €26 % *
Credit history
No. of unpaid debts
0
Largest debt
VID
Amount of unpaid debts
€0.00
Oldest open debt
-
No. of unpaid debts
0
Largest debt
VID
Amount of unpaid debts
€0.00
Oldest open debt
-
Credit report
Creditor/Data source  | Debt amount | Debt date | Debt type |
|---|---|---|---|
- | - | - | - |
Creditor/Data source | Debt amount | Debt date | Payment date | Debt type |
|---|---|---|---|---|
- | - | - | - | - |
Legal proceedings
Defendant
(0)
Plaintiff
(0)
Case No./date | Process parties | Case/Court ruling | Court | No. of court hearings | More |
|---|---|---|---|---|---|
| - | - | - | - | - | - |
Case No./date | Process parties | Case/Court ruling | Court | No. of court hearings | More |
|---|---|---|---|---|---|
| - | - | - | - | - | - |
Public data
Data source | Information | Additional data |
|---|---|---|
 | Total amount of taxes administered by the SRS and paid by taxpayers within the tax year 2022 | Total amount: 77,860 |
| Total amount of taxes administered by the SRS and paid by taxpayers within the tax year 2021 | Total amount: 36,280 |
| Total amount of taxes administered by the SRS and paid by taxpayers within the tax year 2020 | Total amount: 61,140 |
| Total amount of taxes administered by the SRS and paid by taxpayers within the tax year 2019 | Total amount: 19,820 |
| Total amount of taxes administered by the SRS and paid by taxpayers within the tax year 2018
| Total amount: 56,410 |
Similar companies
Category:
Wholesale of pharmaceutical products and medical suppliesComp. code:
40203653169Reg. date:
02/06/2025Turnover:
-No. of employees:
3Category:
Wholesale of pharmaceutical products and medical suppliesComp. code:
40203537360Reg. date:
02/02/2024Turnover:
-No. of employees:
3Category:
Wholesale of pharmaceutical products and medical suppliesComp. code:
40203533462Reg. date:
17/01/2024Turnover:
-No. of employees:
2Category:
Wholesale of pharmaceutical products and medical suppliesComp. code:
40203497049Reg. date:
20/07/2023Turnover:
-No. of employees:
2Category:
Wholesale of pharmaceutical products and medical suppliesComp. code:
40203444643Reg. date:
30/11/2022Turnover:
-No. of employees:
3Frequently Asked Questions
What is the current status of SIA "Ingen Pharma"?
SIA "Ingen Pharma" is currently Registered. It was registered on 12/01/2011.
What is SIA "Ingen Pharma" registered address?
SIA "Ingen Pharma" registered address is Kārļa Ulmaņa gatve 119, Mārupe, Mārupes nov., LV-2167.
What is SIA "Ingen Pharma" activity?
SIA "Ingen Pharma" operates in Wholesale of pharmaceutical products and medical supplies (46.46 - NACE 2.1).
How many employees does SIA "Ingen Pharma" have?
SIA "Ingen Pharma" has 3 employees (2025).
Is SIA "Ingen Pharma" a reliable company?
SIA "Ingen Pharma" Pre-Score* rating is A, which indicates the highest level of reliability.
* The credit score is calculated based on financial data, payment history, and other risk indicators.What is the annual turnover of SIA "Ingen Pharma"?
SIA "Ingen Pharma" reported a turnover of 5,098,411 EUR in 2025.
Does SIA "Ingen Pharma" have any current state debt?
SIA "Ingen Pharma" currently has no outstanding state debt.